MAPT and Alzheimer disease: Alzheimer’s disease (AD) is characterized by the pathological accumulation of beta-amyloid (Aβ) peptides and tau-protein neurofibrillary tangles, followed by neuronal injury and severe cognitive impairment (Hardy and Selkoe, 2002; Jack et al., 2013).